Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma
Children with recurrent/metastatic neuroblastoma (NB) have a dismal survival (<25%). Novel therapies are desperately needed. Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is highly expressed on NB. C021 is a selective oncolytic herpes simplex virus modified to overexpress human interleuk...
Saved in:
Main Authors: | Yaya Chu, Meijuan Tian, Uksha Saini, Jessica Ayala-Cuesta, Kayleigh Klose, Alyssa S. Mendelowitz, Keira Foley, Mehmet F. Ozkaynak, Wen Luo, Timothy P. Cripe, Dean A. Lee, Kevin A. Cassady, Mitchell S. Cairo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Molecular Therapy: Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2950329924001693 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ROR1 CAR-T cells and ferroptosis inducers orchestrate tumor ferroptosis via PC-PUFA2
by: Dan Li, et al.
Published: (2025-01-01) -
Improving systemic delivery of oncolytic virus by cellular carriers
by: Ziyi Peng, et al.
Published: (2024-12-01) -
Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients
by: Emre LEVENTOGLU, et al.
Published: (2023-06-01) -
Adult-onset Renal Neuroblastoma: Case Report and Literature Review
by: Yao-Ren Yang, et al.
Published: (2024-12-01) -
Deep learning for stage prediction in neuroblastoma using gene expression data
by: Aron Park, et al.
Published: (2019-09-01)